ERBB2 and cancer: Low oCICs, at a cutoff of 15 CICs/core, were significantly associated with shorter survival of Luminal B (Her2+) patients (mOS: 95 months vs. not reached, P = 0.008; Figure 4C), but not other cancer subtypes.